Literature DB >> 1174403

Anterior chamber depth and primary angle-closure glaucoma. II. A genetic study.

P H Alsbirk.   

Abstract

The genetics of primary angle-closure glaucome (a.c.g.) was studied: a) through the prevalence in sibs and children of a.c.g. probands, and b) through the family distribution of the closely correlated axial anterior chamber depth (ACD). The material emerged from an epidemiologic study in Greeland Eskimos. a) Compared with the general population, the observed prevalence of a.c.g. was increased in sibs of a.c.g. probands and the estimated, future prevalence was found to be the same in sibs and children. Age influence prevented a proper Mendelian analysis, but no simple monogenic inheritance seems probable. b) The biometric study showed a relatively shallow chamber in sibs, children, nephews, nieces and grandchildren of a.c.g. probands. Regression analyses revealed a corresponding pattern, also in control families of probands with shallow chambers and in general population families. A heritability of 70% was found, indicating that about two thirds of the age and sex independent variation in ACD seems to be genetic.

Entities:  

Mesh:

Year:  1975        PMID: 1174403     DOI: 10.1111/j.1755-3768.1975.tb01175.x

Source DB:  PubMed          Journal:  Acta Ophthalmol (Copenh)        ISSN: 0001-639X


  11 in total

Review 1.  The genetic mechanisms of primary angle closure glaucoma.

Authors:  D F Ahram; W L Alward; M H Kuehn
Journal:  Eye (Lond)       Date:  2015-07-24       Impact factor: 3.775

2.  Anterior chamber depth in open angle glaucoma.

Authors:  J Caprioli; G L Spaeth; R P Wilson
Journal:  Br J Ophthalmol       Date:  1986-11       Impact factor: 4.638

3.  Susceptibility to primary angle closure glaucoma in Saudi Arabia: the possible role of mitochondrial DNA ancestry informative haplogroups.

Authors:  Khaled K Abu-Amero; Ana M González; Essam A Osman; José M Larruga; Vicente M Cabrera; Saleh A Al-Obeidan
Journal:  Mol Vis       Date:  2011-08-12       Impact factor: 2.367

4.  Identification of genetic loci associated with primary angle-closure glaucoma in the basset hound.

Authors:  Dina F Ahram; Amy C Cook; Helga Kecova; Sinisa D Grozdanic; Markus H Kuehn
Journal:  Mol Vis       Date:  2014-04-25       Impact factor: 2.367

5.  Ethnic differences in lens parameters measured by ocular biometry in a cataract surgery population.

Authors:  Dajiang Wang; Behzad Amoozgar; Travis Porco; Zhen Wang; Shan C Lin
Journal:  PLoS One       Date:  2017-06-27       Impact factor: 3.240

6.  Molecular analysis of CHX10 and MFRP in Chinese subjects with primary angle closure glaucoma and short axial length eyes.

Authors:  Tin Aung; Marcus C C Lim; Tina T L Wong; Anbupalam Thalamuthu; Victor H K Yong; Divya Venkataraman; Anandalakshmi Venkatraman; Paul T K Chew; Eranga N Vithana
Journal:  Mol Vis       Date:  2008-07-17       Impact factor: 2.367

7.  A catalase promoter variant rs1001179 is associated with visual acuity but not with primary angle closure glaucoma in Saudi patients.

Authors:  Khaled K Abu-Amero; Taif Anwar Azad; Ahmed Mousa; Essam A Osman; Tahira Sultan; Saleh A Al-Obeidan
Journal:  BMC Med Genet       Date:  2013-08-20       Impact factor: 2.103

8.  Total antioxidant level is correlated with intra-ocular pressure in patients with primary angle closure glaucoma.

Authors:  Khaled K Abu-Amero; Taif Anwar Azad; Ahmed Mousa; Essam A Osman; Tahira Sultan; Saleh A Al-Obeidan
Journal:  BMC Res Notes       Date:  2014-03-19

9.  Evaluation of PRSS56 in Chinese subjects with high hyperopia or primary angle-closure glaucoma.

Authors:  Dan Jiang; Zhikuan Yang; Shiqiang Li; Xueshan Xiao; Xiaoyun Jia; Panfeng Wang; Xiangming Guo; Xing Liu; Qingjiong Zhang
Journal:  Mol Vis       Date:  2013-11-07       Impact factor: 2.367

Review 10.  A survey on computer aided diagnosis for ocular diseases.

Authors:  Zhuo Zhang; Ruchir Srivastava; Huiying Liu; Xiangyu Chen; Lixin Duan; Damon Wing Kee Wong; Chee Keong Kwoh; Tien Yin Wong; Jiang Liu
Journal:  BMC Med Inform Decis Mak       Date:  2014-08-31       Impact factor: 2.796

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.